The data shown below were collected from the profiles of 95 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
|
|---|---|
| Published in |
Cancer Discovery, April 2023
|
| DOI | 10.1158/2159-8290.cd-22-0601 |
| Pubmed ID | |
| Authors |
Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, Wafa Al-Santli, Hua Zhou, Bettina Nadorp, Soobeom Lee, Audrey Lasry, Zhengxi Sun, Dimitrios Papaioannou, Michael Cammer, Kun Wang, Tomasz Zal, Malgorzata Anna Zal, Bing Z Carter, Jo Ishizawa, Raoul Tibes, Aristotelis Tsirigos, Michael Andreeff, Evripidis Gavathiotis, Iannis Aifantis |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 16 | 17% |
| Germany | 2 | 2% |
| Canada | 2 | 2% |
| France | 1 | 1% |
| Belgium | 1 | 1% |
| Italy | 1 | 1% |
| India | 1 | 1% |
| Spain | 1 | 1% |
| Denmark | 1 | 1% |
| Other | 2 | 2% |
| Unknown | 67 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 48% |
| Scientists | 38 | 40% |
| Practitioners (doctors, other healthcare professionals) | 7 | 7% |
| Science communicators (journalists, bloggers, editors) | 4 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 5 | 18% |
| Researcher | 4 | 14% |
| Student > Master | 2 | 7% |
| Student > Ph. D. Student | 2 | 7% |
| Other | 1 | 4% |
| Other | 2 | 7% |
| Unknown | 12 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 5 | 18% |
| Biochemistry, Genetics and Molecular Biology | 5 | 18% |
| Medicine and Dentistry | 3 | 11% |
| Nursing and Health Professions | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 2 | 7% |
| Unknown | 11 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 513. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2024.
All research outputs
#52,258
of 26,312,809 outputs
Outputs from Cancer Discovery
#20
of 4,211 outputs
Outputs of similar age
#1,429
of 420,584 outputs
Outputs of similar age from Cancer Discovery
#2
of 114 outputs
Altmetric has tracked 26,312,809 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.